Category: Latest News
-
AngloGold Ashanti closes record year with solid Q4 and $1.8B in dividends
AngloGold Ashanti (NYSE:AU) delivered fourth-quarter results that met earnings expectations and surpassed revenue forecasts, rounding out what the company described as a record year for cash generation and shareholder distributions. Shares slipped 1.25% in pre-market trading following the release. For the fourth quarter, the miner posted earnings of $1.90 per share, in line with analyst…
-
Balchem rises more than 4% after record Q4 and full-year performance
Balchem Corporation (NASDAQ:BCPC) reported fourth-quarter results that exceeded Wall Street expectations, sending shares up 4.46% in pre-market trading. Adjusted earnings per share came in at $1.31, ahead of the $1.18 consensus forecast. Revenue reached $263.6 million, surpassing analysts’ expectations of $259.6 million and marking a 9.8% increase compared with the same quarter last year. On…
-
Eldorado Gold beats Q4 forecasts as output reaches top end of guidance
Eldorado Gold (NYSE:EGO) delivered better-than-expected fourth-quarter results, surpassing analyst estimates for both earnings and revenue, supported by solid production levels and strong gold prices. Despite the earnings beat, shares were down 4.89% in pre-market trading following the announcement. The company reported earnings per share of $0.63 for the fourth quarter, exceeding the $0.52 consensus estimate.…
-
AdvanSix reports solid Q4 revenue growth, but profits trail forecasts
AdvanSix (NYSE:ASIX) delivered mixed results for the fourth quarter of 2025, posting healthy year-over-year sales growth and stronger operating metrics, though earnings failed to meet analyst expectations. Shares ticked up 0.11% in after-hours trading following the announcement. Quarterly revenue totaled $359.9 million, marking a 9% increase from $329.1 million in the same period last year.…
-
Telephone & Data Systems rises more than 5% after Q4 earnings and revenue top estimates
Shares of Telephone and Data Systems, Inc. (NYSE: TDS) climbed over 5% in premarket trading Friday after the company delivered fourth-quarter results that exceeded Wall Street forecasts, closing what executives called a pivotal year for the business. For the quarter, TDS reported earnings per share of $0.32, comfortably above the consensus estimate of $0.09 —…
-
FT: Amazon cloud faced two December disruptions linked to internal AI tools
Amazon’s (NASDAQ:AMZN) cloud division experienced at least two service interruptions in December tied to issues involving its own artificial intelligence systems, the Financial Times reported on Friday, citing sources familiar with the matter. According to the report, Amazon Web Services (AWS) suffered a roughly 13-hour disruption in mid-December that affected a customer-facing system after engineers…
-
Exclusive: Netflix has financial firepower to sweeten Warner Bros bid if rivalry intensifies, sources say
Netflix (NASDAQ:NFLX) has significant cash reserves and retains the flexibility to raise its offer for Warner Bros Discovery (NASDAQ:WBD) should rival bidder Paramount Skydance improve its proposal, according to two people familiar with the situation. The streaming heavyweight and the rival studio have been engaged in a high-stakes contest for Warner Bros and its vast…
-
Tesla rolls out lower-cost Cybertruck option, trims Cyberbeast price amid softer demand
Tesla (NASDAQ:TSLA) introduced a more affordable version of its Cybertruck in the U.S. on Thursday and reduced the price of its top-tier Cyberbeast model, as the electric vehicle manufacturer works to stimulate demand for its pickup lineup. The company set the price of the new dual-motor, all-wheel-drive Cybertruck at $59,990, positioning it as the brand’s…
-
Grail stock tumbles after pivotal trial misses main goal
Shares of Grail (NASDAQ:GRAL) plunged almost 47% in premarket trading on Friday after the company announced that its landmark NHS-Galleri study did not achieve its primary endpoint — a statistically significant drop in late-stage (Stage III and IV) cancer diagnoses. Despite the clinical setback, the California-based biotech posted fourth-quarter results that exceeded expectations. The company…
-
Oil set for first weekly rise in three weeks as US-Iran tensions escalate
Oil prices advanced on Friday and were on track to post their first weekly gain in three weeks, as mounting fears of a potential confrontation between the United States and Iran unsettled markets. The move followed Washington’s warning that Tehran could face consequences within days if it fails to reach an agreement over its nuclear…